Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPA3 | P15088 | 1/20 | 0.56 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | CA7 | P43166 | 2/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.45 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1373606 | 0.78 | CPA3 (0.66) | CPA3FOLH1NAALAD2CYP1A2 | |
| SCHEMBL13585095 | 0.76 | CA2 (0.51) | SLC1A1CA2CA12CA7CA14 | |
| SCHEMBL13585100 | 0.76 | CA2 (0.51) | SLC1A1CA2CA12CA7CA14 | |
| SCHEMBL1377040 | 0.75 | CPA3 (0.62) | CPA3FOLH1CA2NAALAD2CYP1A2 | |
| SCHEMBL7052257 | 0.74 | CPA3 (0.60) | CPA3FOLH1NAALAD2CYP1A2 | |
| SCHEMBL1377052 | 0.74 | CPA3 (0.56) | CPA3FOLH1ALDH1A1CYP1A2CYP2D6 | |
| SCHEMBL7279703 | 0.74 | CA12 (0.47) | CA2CA12CA7CA14CA1 | |
| SCHEMBL1376180 | 0.73 | CPA3 (0.59) | CPA3FOLH1CA2CYP1A2 | |
| SCHEMBL9615080 | 0.73 | CA12 (0.59) | CA2CA12CA7CA14CA1 | |
| SCHEMBL3963424 | 0.73 | CPA3 (1.00) | CPA3FOLH1SLC1A1NAALAD2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2002514185-A | — | — | 2002-05-14 | — | — | JP | claimed |
| EP-0949922-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING COMPULSIVE DISORDERS USING NAALADASE INHIBITORS | GUILFORD PHARMACEUTICALS INC. (US) | 1999-10-20 | — | — | EP | claimed |
| WO-1998013044-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING COMPULSIVE DISORDERS USING NAALADASE INHIBITORS | GUILFORD PHARMACEUTICALS INC. (US) | 1998-04-02 | — | — | WO | claimed |